Marinomed Biotech AG

About Marinomed Biotech AG

Marinomed Biotech AG is an Austrian biopharmaceutical company specializing in the development of innovative products based on IP protected technology platforms, such as Marinosolv® and Carragelose®. The Solv4U partnerships program addresses the challenge of hardly soluble APIs in drug development and relies on the clinically proven technology Marinosolv® by customized aqueous formulations, in order to improve the bioavailability and thereby therapeutic efficacy.

  • AT
  • 2020
    On CPHI since
  • 25 - 49
    Employees
Company types
Biopharmaceutical company
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Biopharmaceutical
Contract Research Organisation
Laboratory Services
Medical Devices
Pharmaceutical Company (innovator finished products)
Contact info

Products from Marinomed Biotech AG (5)

  • Carragelose eye drops

    Product Carragelose eye drops

    The Carragelose eye drops are intended to provide relief for dry eyes. Carragelose has excellent moistuirizing properties, an outstanding safety profile and is known for its virus-blocking effectiveness.
  • Carragelose nasal spray

    Product Carragelose nasal spray

    white label licensing of different formulations containing Carragelose to prevent and treat common cold and allergy
  • Tacrosolv

    Product Tacrosolv

    Tacrosolv is a topically applied, anti-inflammatory and immunomodulating ophthalmic solution, containing Tacrolimus solubilized with Marinomeds proprietary Marinosolv solubilization technology.
  • Budesolv

    Product Budesolv

    novel preservative-free budesonide nasal spray, IP protected formulation
  • Solv4U

    Product Solv4U

    Poor water solubility of drug candidates is one of the most common hurdles pharmaceutical development is confronted with. Promising new chemical entities and drug candidates often fail in development due to the limitations of their solubility in water.

    Marinomed Biotech AG provides Solv4U techno...

Marinomed Biotech AG Resources (1)